Open AccessInefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori
Author(s) -
Murat Kekilli,
İbrahi̇m Koral Önal,
Serkan Öcal,
Zeynal Doğan,
Alpaslan Tanoğlu
Publication year - 2016
Publication title -
the saudi journal of gastroenterology/saudi journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 32
eISSN - 1998-4049
pISSN - 1319-3767
DOI - 10.4103/1319-3767.191141
Subject(s) - lansoprazole , medicine , helicobacter pylori , clarithromycin , amoxicillin , metronidazole , gastroenterology , group b , bismuth , urea breath test , breath test , antibiotics , helicobacter pylori infection , microbiology and biotechnology , chemistry , organic chemistry , biology
Increasing resistance of Helicobacter pylori to antimicrobials necessitated the development of new regimens and the modification of existing regimens. The present study aimed to compare the efficacy of two bismuth-containing quadruple regimens-one including clarithromycin (C) instead of metronidazole (M) and triple therapy.